FDA Approved Products

6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
LEVLITE
ethinyl estradiol; levonorgestrel
LOE Approaching
Bayer
ORAL-28 · TABLET
1998
NDA
30/100
LEVO-DROMORAN
levorphanol tartrate
LOE Approaching
Bausch + Lomb
ORAL · TABLET
1953
NDA
30/100
LEVO-DROMORAN
levorphanol tartrate
LOE Approaching
Bausch + Lomb
INJECTION · INJECTABLE
1953
NDA
30/100
LEVO-T
levothyroxine sodium
LOE Approaching
ORAL · TABLET
hypothyroidism during the recovery phase of subacute thyroiditis
2002
NDA
30/100
LEVOLEUCOVORIN CALCIUM
levoleucovorin calcium
Peak
Teva
INTRAVENOUS · POWDER
2016
NDA
30/100
LEVONORGESTREL
levonorgestrel
LOE Approaching
Pfizer
IMPLANTATION · IMPLANT
1996
NDA
30/100
LEVOPHED
norepinephrine bitartrate
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1950
NDA
30/100
LEVOXYL
levothyroxine sodium
LOE Approaching
Pfizer
ORAL · TABLET
hypothyroidism during the recovery phase of subacute thyroiditissecondary (pituitary)+3
2001
NDA
30/100
LEXAPRO
escitalopram oxalate
LOE Approaching
Forest Devices
ORAL · TABLET
2002
NDA
30/100
LEXIVA
fosamprenavir calcium
LOE Approaching
GSK
ORAL · SUSPENSION
2007
NDA
30/100
LEXIVA
fosamprenavir calcium
LOE Approaching
GSK
ORAL · TABLET
2003
NDA
30/100
LEXXEL
enalapril maleate; felodipine
LOE Approaching
AstraZeneca
ORAL · TABLET, EXTENDED RELEASE
1996
SMNDA
30/100
LIALDA
mesalamine
LOE Approaching
Takeda
ORAL · TABLET, DELAYED RELEASE
ulcerative colitis
2007
NDA
30/100
LIBRAX
chlordiazepoxide hydrochloride and clidinium bromide
LOE Approaching
Bausch + Lomb
ORAL · CAPSULE
1966
NDA
30/100
LIBRELEASE
chlordiazepoxide
LOE Approaching
Bausch + Lomb
ORAL · CAPSULE, EXTENDED RELEASE
1983
NDA
30/100
LIBRIUM
chlordiazepoxide hydrochloride
LOE Approaching
Bausch + Lomb
INJECTION · INJECTABLE
1961
NDA
30/100
LIBRIUM
chlordiazepoxide hydrochloride
LOE Approaching
Bausch + Lomb
ORAL · CAPSULE
1960
NDA
30/100
LIDEX
fluocinonide
LOE Approaching
Alvogen
TOPICAL · OINTMENT
1971
NDA
30/100
LIDEX
fluocinonide
LOE Approaching
Alvogen
TOPICAL · SOLUTION
1984
NDA
30/100
LIDEX
fluocinonide
LOE Approaching
Alvogen
TOPICAL · CREAM
1971
NDA
30/100
LIDEX-E
fluocinonide
LOE Approaching
Alvogen
TOPICAL · CREAM
1971
NDA
30/100
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
LOE Approaching
Medica Corp
INJECTION · INJECTABLE
1976
NDA
30/100
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
LOE Approaching
Bristol Myers Squibb
INJECTION · INJECTABLE
1976
NDA
30/100
LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride
LOE Approaching
Baxter
INJECTION · INJECTABLE
the acute management of (1) ventricular arrhythmias occurring during cardiac manipulationssuch
1981
NDA
30/100
← PreviousPage 96 of 277Next →